TGFB1 and acute myeloid leukemia: KEGG pathway enrichment analyses revealed that the DEGs participated in acute myeloid leukemia (p = 0.04), TGF‐β signaling pathway (p = 0.04), endocrine resistance (p = 0.04), and parathyroid hormone synthesis, secretion, and action (p = 0.04) (Table 3).